Enjoy complimentary access to the Clinical Cancer Research Breast Cancer article collection for a limited time!
- Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial
Ciruelos E…Prat A Clinical Cancer Research November 2020. - Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer
Richard F…Desmedt C Clinical Cancer Research OnlineFirst: October 15, 2020. - Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer
Mao P…Wagle N Clinical Cancer Research November 2020. - A novel neoplastic fusion transcript, RAD51AP1-DYRK4, confers sensitivity to the MEK inhibitor trametinib in aggressive breast cancers
Liu CC…Wang XS Clinical Cancer Research OnlineFirst: November 10, 2020. - Prognostic Value of EndoPredict in Women with Hormone Receptor–Positive, HER2-Negative Invasive Lobular Breast Cancer
Sestak I…Dubsky P Clinical Cancer Research September 2020. - Immune infiltrate in the primary tumor predicts effect of adjuvant radiotherapy in breast cancer; results from the randomized SweBCG91RT trial
Tullberg AS…Karlsson P Clinical Cancer Research OnlineFirst: November 4, 2020. - Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer
Axelrod ML…Balko JM Clinical Cancer Research November 2020. - A Prognostic Model Based on PAM50 and Clinical Variables (PAM50MET) for Metastatic Hormone Receptor–positive HER2-negative Breast Cancer
Prat A…Parker JS Clinical Cancer Research OnlineFirst: October 22, 2020. - A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–Positive Breast Cancer
Tolaney SM…Anders CK Clinical Cancer Research October 2020.
Clinical Cancer Research Editorial Office
American Association for Cancer Research | Publications Division
615 Chestnut Street | 17th Floor | Philadelphia, PA 19106-4404
Phone: (215)40-9300 | Fax: (215) 440-9354 | E-mail: ccr@aacr.org